Black Rock Inc. Logic Bio Therapeutics, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.67 $1,017 - $2,351	-3,509 Reduced 2.01%	170,945 $47,000
Q2 2022 Aug 12, 2022	SELL	$0.35 - $0.74 $14,581 - $30,829	-41,662 Reduced 19.28%	174,454 $61,000
Q1 2022 May 12, 2022	SELL	$0.61 - $2.49 $1,520 - $6,207	-2,493 Reduced 1.14%	216,116 $146,000
Q4 2021 Feb 10, 2022	BUY	$2.2 - $4.53 $6,320 - $13,014	2,873 Added 1.33%	218,609 $506,000
Q3 2021 Nov 09, 2021	SELL	$3.85 - $5.09 $20,836 - $27,547	-5,412 Reduced 2.45%	215,736 $988,000
Q2 2021 Aug 11, 2021	BUY	$4.03 - $7.57 $891,226 - $1.67 Million	221,148 New	221,148 $982,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.